Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Microb Cell Fact ; 16(1): 16, 2017 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-28137256

RESUMO

BACKGROUND: Through functional screening of a fosmid library, generated from a phytopathogen-suppressive soil metagenome, the novel antifungal chitinase-named Chi18H8 and belonging to family 18 glycosyl hydrolases-was previously discovered. The initial extremely low yield of Chi18H8 recombinant production and purification from Escherichia coli cells (21 µg/g cell) limited its characterization, thus preventing further investigation on its biotechnological potential. RESULTS: We report on how we succeeded in producing hundreds of milligrams of pure and biologically active Chi18H8 by developing and scaling up to a high-yielding, 30 L bioreactor process, based on a novel method of mild solubilization of E. coli inclusion bodies in lactic acid aqueous solution, coupled with a single step purification by hydrophobic interaction chromatography. Chi18H8 was characterized as a Ca2+-dependent mesophilic chitobiosidase, active on chitin substrates at acidic pHs and possessing interesting features, such as solvent tolerance, long-term stability in acidic environment and antifungal activity against the phytopathogens Fusarium graminearum and Rhizoctonia solani. Additionally, Chi18H8 was found to operate according to a non-processive endomode of action on a water-soluble chitin-like substrate. CONCLUSIONS: Expression screening of a metagenomic library may allow access to the functional diversity of uncultivable microbiota and to the discovery of novel enzymes useful for biotechnological applications. A persisting bottleneck, however, is the lack of methods for large scale production of metagenome-sourced enzymes from genes of unknown origin in the commonly used microbial hosts. To our knowledge, this is the first report on a novel metagenome-sourced enzyme produced in hundreds-of-milligram amount by recovering the protein in the biologically active form from recombinant E. coli inclusion bodies.


Assuntos
Antifúngicos/farmacologia , Quitinases/metabolismo , Quitinases/farmacologia , Escherichia coli/genética , Hexosaminidases/metabolismo , Hexosaminidases/farmacologia , Microbiologia do Solo , Antifúngicos/isolamento & purificação , Antifúngicos/metabolismo , Reatores Biológicos , Quitina/metabolismo , Quitinases/genética , Quitinases/isolamento & purificação , Clonagem Molecular , Escherichia coli/metabolismo , Fusarium/efeitos dos fármacos , Biblioteca Gênica , Hexosaminidases/genética , Hexosaminidases/isolamento & purificação , Concentração de Íons de Hidrogênio , Interações Hidrofóbicas e Hidrofílicas , Corpos de Inclusão/enzimologia , Ácido Láctico/metabolismo , Metagenoma , Metagenômica/métodos , Filogenia , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacologia , Rhizoctonia/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...